Abstract:Background Smooth muscle cells (SMCs) are a key component of tissue-engineered vessels. However, the sources by which they can be isolated are limited. The generation of induced pluripotent stem (iPS) cells is a useful tool for regenerative medicine. Nevertheless, the risk of tumor development of the aforementioned cells should be addressed before they can be used for clinical applications. During the reprogramming process a number of signal pathways are activated, which may lead to direct differentiation of specific cell lineages prior to the cells reaching the pluripotent state. Methods and Results We hypothesised that a large number of SMCs could be obtained by direct reprogramming of fibroblasts to SMCs. Therefore, we designed a combined protocol of reprogramming and differentiation in an attempt to achieve direct differentiation of fibroblasts to specific cell lineages. Human fibroblasts were shortly reprogrammed by overexpression of four reprogramming factors (OCT4, SOX2, KLF4 and c-MYC) and maintained in reprogramming media on a gelatin substrate for four days. These cells were defined as partially induced pluripotent stem (PiPS) cells. PiPS cells did not form tumors in vivo and differentiated into SMCs when seeded on a collagen IV substrate and maintained in differentiation media. The PiPS-SMCs expressed a panel of SMC markers such as SMA, SM22 and calponin at mRNA and protein levels. In order to elucidate the mechanism of PiPS cell differentiation into SMCs, data from a series of experiments indicated that the gene DKK3 was involved in this differentiation. DKK3 was expressed in parallel with SMC markers, while its overexpression or stimulation induced SMC marker expression. Furthermore, DKK3 silencing resulted in downregulation of SMC markers on both the mRNA and protein levels. Additional experiments revealed that the upregulation of SMC markers by DKK3 is mediated by interaction of DKK3 with the transmembrane receptor Kremen 1, potentiation of Wnt signalling and ultimately β-catenin translocation. Finally, PiPS-SMCs repopulated decellularised vessel grafts and ultimately gave rise to functional tissue-engineered vessels when combined with the previously established PiPS-endothelial cells, leading to increased survival of SCID mice after transplantation of the vessel as a vascular graft. Conclusion In the present study, we have developed a protocol to generate SMCs from PiPS cells through a DKK3 signalling pathway, which are useful for generating functional tissue-engineered vessels. These findings provide new insight into the mechanisms of SMC differentiation with vast therapeutic potential.

Differentiation of smooth muscle progenitor cells in peripheral blood and its application in tissue engineered blood vessels

Fabrication of a tubular vascular scaffold with circumferential microchannels to induce oriented growth of smooth muscle cells

An Experimental Research on Construction of Tissue Engineering Blood Vessel Scaffold with Cells from Bone Marrow Mononuclear Cells

Engineering Vascular Tissue with Functional Smooth Muscle Cells Derived from Human Ips Cells and Nanofibrous Scaffolds.

Derivation of Functional Smooth Muscle Cells from Integration-Free Induced Pluripotent Stem Cells Through Cardiovascular Progenitor Cell Intermediates for Vascular Regeneration

A Comparison of Murine Smooth Muscle Cells Generated from Embryonic Versus Induced Pluripotent Stem Cells

Tissue Engineering of Blood Vessels with Endothelial Cells Differentiated from Mouse Embryonic Stem Cells

Abstract 302: Generation of Patient-Specific Tissue-Engineered Blood Vessels from Nonintegrated Induced Pluripotent Stem Cells

Smooth Muscle Cells Differentiated from Reprogrammed Embryonic Lung Fibroblasts Through DKK3 Signaling Are Potent for Tissue Engineering of Vascular Grafts.

Patient-specific Cardiovascular Progenitor Cells Derived from Integration-Free Induced Pluripotent Stem Cells for Vascular Tissue Regeneration

Abstract 650: Stem Cell-derived SMCs Are Useful for Vascular Tissue Engineering

Construction of Vascular Tissues with Macro-Porous Nano-Fibrous Scaffolds and Smooth Muscle Cells Enriched from Differentiated Embryonic Stem Cells.

Functional Tissue-Engineered Blood Vessels from Bone Marrow Progenitor Cells.

Silk Fibroin/chitosan Scaffold with Tunable Properties and Low Inflammatory Response Assists the Differentiation of Bone Marrow Mesenchymal Stem Cells.

The effect of stromal cell-derived factor-1α/heparin coating of biodegradable vascular grafts on the recruitment of both endothelial and smooth muscle progenitor cells for accelerated regeneration.

Three-dimensional growth of iPS cell-derived smooth muscle cells on nanofibrous scaffolds

A small diameter elastic blood vessel wall prepared under pulsatile conditions from polyglycolic acid mesh and smooth muscle cells differentiated from adipose-derived stem cells.

SMOOTH MUSCLE CELLS DIFFERENTIATED FROM REPROGRAMMED FIBROBLASTS THROUGH DKK3 SIGNALLING ARE POTENT FOR TISSUE ENGINEERING OF VASCULAR GRAFTS

Tissue Engineering of Blood Vessels: Characterization of Smooth-Muscle Cells for Culturing on Collagen-And-Elastin-Based Scaffolds

Embryonic Mesenchymal Multipotent Cell Differentiation on Electrospun Biodegradable Poly(ester amide) Scaffolds for Model Vascular Tissue Fabrication

A Novel Scaffold for Endothelial Progenitor Cells in Tissue Engineered Vascular Grafts